Search

everythinglearnresearchcommunity

for

Search:↓

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

A new method helps manage skin side effects from hormonal cancer therapy, improving patient care.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Promising cancer treatments were found, but the manufacturer closed.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Pulsed electric field treatment may help shrink untreated liver tumors.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Oral dutasteride, minoxidil, and finasteride may help reduce hair loss in breast cancer survivors, but more research is needed.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Hair loss is a common side effect of hormone treatments for cancer.

Removing an adrenal tumor can significantly reduce high androgen levels in postmenopausal women.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Anastrozole can cause increased testosterone, leading to symptoms like hair growth and thinning.

Hair loss can occur as a side effect of certain breast cancer treatments, but minoxidil can help regrow hair.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.